DRKS00016973招募中不适用
Design and implementation of a national multicenter registry for pediatric patients with CNS lesions treated with robotic radiosurgery
Charité Campus Virchow-Klinikum0 个研究点目标入组 200 人开始时间: 2019年3月18日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 0 Years 至 17 Years（—）
- 性别
- All
入选标准
- •age < 18, diagnosis of CNS lesion, interdisciplinary consent for radiosurgical intervention, possibility of consecutive follow up controls, consent form signed by both parents (and child depending on his/her age)
排除标准
- •age of 18 or older, pregnancy, breast feeding
研究者
相似试验
尚未招募
Unknown
The AFRICA-FINGERS ProjectMental and Behavioural DisordersPACTR202407499314703Aga Khan University kenya600
招募中
Unknown
Establishment and evaluation of a structured, multidisciplinary, guideline-based transition and (long-term) aftercare for children and adolescents formerly affected by cancerCancer of any kindC00-C97Malignant neoplasmsDRKS00029269niversitätsklinikum Schleswig-Holstein, Campus Lübeck1,600
尚未招募
Unknown
Comprehensive Coordinated Community based Palliative Care (C3PaC) model for Cancer Patients in North India: a mixed-method implementational research study protocol.CTRI/2023/04/051357India Cancer Research Consortium, ICMR, NEW DELHI
进行中（未招募）
不适用
A prospective, open-label, international, multicenter trial to investigate the efficacy and safety of NT 201, free of complexing proteins, in the treatment of glabellar frown lines - NT-SPUTNIKEUCTR2008-000549-73-DEMerz Pharmaceuticals GmbH101
进行中（未招募）
不适用
A Multi-National, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Parallel Group Study to Assess the Efficacy, Tolerability and Safety of Three Doses of Edratide TV-4710 for Injection Administered Subcutaneously to Systemic Lupus Erythematosus SLE patientsTreatment of active SLE patients who are concurrently undergoing a regimented program of decreased steroid use.MedDRA version: 6.1Level: PTClassification code 10042945EUCTR2005-001391-12-ITTEVA260